
      2012”N@‰¢•¶
    Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaoka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A,Yoshida M, Nakahata T, Takahashi R, Marchetto MCN, Gage FH, Yamanaka S, Inoue (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Science Translational Medicine 4:1-8
    Furuta N, Ikeda M, Hirayanagi K, Fujita Y, Amanuma M, Okamoto K (2012) A novel GJA1 mutation in oculodentodigital dysplasia with progressive spastic paraplegia and sensory deficts. Intern Med 51; 93-98
    Hashimoto Y, Muramatsu K, Kunii M, Yoshimura S, Yamada M, Sato T, Ishida
    Y, Harada R, Harada A (2012) Uncovering genes required for neuronal morphology
    by morphology-based gene trap screening with a revertible retrovirus vector.
    FASEB J 26; 4662-4674
    Ikeda M, Hirayanagi K, Arai M, Kakuda S, Makioka K, Furuta N, Takai E,
    Kasahara H, Tsukagoshi S, Fujita Y, Amari M, Takatama M, Nakazato Y, Okamoto
    K. 2012)@Encephalopathy with amyloid angiopathy and numerous plaques in
    low levels of CSF AƒÀ1-40/AƒÀ1-42. Amyloid 19; 186-90
    Ikeda Y, Ohta Y, Kobayashi H, Okamoto M, Takamatsu K, Ota T, Manabe Y,
    Okamoto K, Koizumi A, Abe K (2012) Clinical features of ACA36. A novel
    spinocerebellar ataxia with motor neuron involvement (Asidan). Neurology
    79; 333-341
    Makioka K, Yamazaki T, Takatama M, Nakazato Y, Okamoto K (2012) Activation and alteration of lysosomes in multiple system atrophy. Neuroreport 23; 270-276
    Mizuno Y, Fujita Y, Takatama M, Okamoto K (2012) Comparison of phosphorylated
    TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS
    and ALS disorders. J Neurol Sci 315; 20-25
    Nawa M, Kage-Nakadai E, Aiso S, Okmaoto K, Mitani A, Matsuoka M (2012)
    The reduced Expression of BTBD10, an Akt Activator, is neurotoxic and possibly
    contributes to the ALS pathogenesis. Cell Death Differ 19; 1398-407
    Sohmiya M, Wada N, Tazawa M, Okamoto K, Shirakura K (2012) Immediate effects
    of physical therapy on gait disturbance and@frontal assessment battery
    in Parkinsonfs disease. Geriatr Gerontol Int 13; 630-7
    Ushikubo M, Okamoto K (2012) Circumstances surrounding death and nursing difficulties with end-of-life
    care for individuals with ALS in central Japan.Int J Palliat Nurs 18; 554-60